Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, Co. Mayo, Ireland
LUMIGAN 0.1 mg/ml eye drops, solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. Colourless solution. |
One ml of solution contains 0.1 mg bimatoprost.
Excipient with known effect: One ml of solution contains 0.2 mg benzalkonium chloride.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F2α (PGF2α), that does not act through any known prostaglandin receptors. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
White opaque low density polyethylene bottles with polystyrene screw cap. Each bottle has a fill volume of 3 ml.
The following pack sizes are available: cartons containing 1 or 3 bottles of 3 ml solution. Not all pack sizes may be marketed.
Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, Co. Mayo, Ireland
EU/1/02/205/003-004
07 January 2010
| Drug | Countries | |
|---|---|---|
| LUMIGAN | Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.